Page last updated: 2024-10-24

cetirizine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

cetirizine has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 1 studies

Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.

Research Excerpts

ExcerptRelevanceReference
"Recently, we reported that chlorcyclizine (CCZ, Rac-2), an over-the-counter antihistamine piperazine drug, possesses in vitro and in vivo activity against hepatitis C virus."7.83Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. ( Dulcey, AE; Ferrer, M; He, S; Hu, X; Hu, Z; Liang, TJ; Lin, B; Marugan, JJ; Rolt, A; Southall, N; Wang, AQ; Xiao, J; Xu, X; Zheng, W, 2016)
"Recently, we reported that chlorcyclizine (CCZ, Rac-2), an over-the-counter antihistamine piperazine drug, possesses in vitro and in vivo activity against hepatitis C virus."3.83Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection. ( Dulcey, AE; Ferrer, M; He, S; Hu, X; Hu, Z; Liang, TJ; Lin, B; Marugan, JJ; Rolt, A; Southall, N; Wang, AQ; Xiao, J; Xu, X; Zheng, W, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, S1
Xiao, J1
Dulcey, AE1
Lin, B1
Rolt, A1
Hu, Z1
Hu, X1
Wang, AQ1
Xu, X1
Southall, N1
Ferrer, M1
Zheng, W1
Liang, TJ1
Marugan, JJ1

Other Studies

1 other study available for cetirizine and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection.
    Journal of medicinal chemistry, 2016, Feb-11, Volume: 59, Issue:3

    Topics: Dose-Response Relationship, Drug; Drug Discovery; Hepacivirus; Hepatitis C; Microbial Sensitivity Te

2016